Other studies have shown that ADGRG1, also known as GPR56 (the adhesion protein-coupled receptor 56) is a marker of LSCs, and its expression on AML cells is significantly associated with the high-risk genetic subgroup and a poor outcome [128]. The gene discussed is ADGRG1; the disease is acute myeloid leukemia.